CRIS Current Research Information System

FAROLFI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.419
NA - Nord America 1.549
EU - Europa 804
SA - Sud America 138
AF - Africa 87
OC - Oceania 3
Totale 5.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.509
SG - Singapore 763
VN - Vietnam 561
CN - Cina 524
HK - Hong Kong 219
IT - Italia 203
BD - Bangladesh 118
DE - Germania 113
BR - Brasile 99
GB - Regno Unito 81
FR - Francia 78
SE - Svezia 62
KR - Corea 55
NL - Olanda 54
IN - India 50
FI - Finlandia 42
CI - Costa d'Avorio 33
IE - Irlanda 32
RU - Federazione Russa 31
JP - Giappone 26
AT - Austria 19
CA - Canada 19
ID - Indonesia 19
AR - Argentina 18
SC - Seychelles 16
CH - Svizzera 14
BG - Bulgaria 13
TH - Thailandia 13
BE - Belgio 12
ES - Italia 12
MX - Messico 12
PH - Filippine 11
UA - Ucraina 11
IQ - Iraq 9
TG - Togo 9
ZA - Sudafrica 9
JO - Giordania 7
TW - Taiwan 7
CL - Cile 6
EC - Ecuador 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
MY - Malesia 4
TR - Turchia 4
AU - Australia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
IR - Iran 3
LT - Lituania 3
PK - Pakistan 3
PL - Polonia 3
TN - Tunisia 3
VE - Venezuela 3
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
LY - Libia 2
NG - Nigeria 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
TJ - Tagikistan 1
TZ - Tanzania 1
Totale 5.000
Salva come PNG Salva come JPEG
Città #
Singapore 534
San Jose 234
Ashburn 232
Hong Kong 203
Ho Chi Minh City 154
Hanoi 151
Santa Clara 137
Hefei 125
Beijing 74
Chandler 70
Boardman 61
Southend 55
Seoul 47
Fairfield 45
Los Angeles 41
Helsinki 39
Lauterbourg 38
Council Bluffs 34
New York 34
Abidjan 33
Dallas 33
Ann Arbor 32
Dublin 32
Buffalo 30
Princeton 26
Rome 24
Da Nang 23
Houston 23
Seattle 22
Bologna 21
Frankfurt am Main 21
Wilmington 20
Tokyo 19
Woodbridge 18
Haiphong 17
Cambridge 16
São Paulo 16
Bengaluru 14
Falkenstein 14
Milan 14
Munich 14
Nuremberg 14
Guangzhou 13
Jakarta 13
Redondo Beach 13
Sofia 13
Shanghai 12
Turin 12
Bern 10
Bangkok 9
Brussels 9
Chicago 9
Lomé 9
Vienna 9
Can Tho 8
Hải Dương 8
Jacksonville 8
London 8
Mexico City 8
Phoenix 8
Shenzhen 8
Amman 7
Brooklyn 7
Düsseldorf 7
Hangzhou 7
San Francisco 7
Shijiazhuang 7
Berlin 6
Denver 6
Des Moines 6
Montescudo 6
Montreal 6
Nanjing 6
Padova 6
Rach Gia 6
Stockholm 6
Baghdad 5
Belo Horizonte 5
Changsha 5
Genoa 5
Jinan 5
Modena 5
Rio de Janeiro 5
Tashkent 5
Tianjin 5
Toronto 5
Tân Tiến 5
Wuhan 5
Atlanta 4
Barcelona 4
Boston 4
Dongguan 4
Florence 4
Fort Worth 4
Harbin 4
Jiaxing 4
Naples 4
Ninh Bình 4
Paris 4
Salvador 4
Totale 3.195
Salva come PNG Salva come JPEG
Nome #
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 201
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 193
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 181
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 173
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice 157
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 150
Early Detection of Cardiotoxicity in Chemotherapy-Treated Patients from Real-time 3D Echocardiography 148
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 147
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 147
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations. 141
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 136
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients? 135
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 135
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients 126
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 125
Taxanes as a Risk Factor for Acute Adverse Reactions to Iodinated Contrast Media in Cancer Patients 115
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 112
Erratum to “Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life” [Eur J Cancer 69 (2016) 110–118] 112
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 111
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer 103
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 97
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide 97
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer 91
Hydroxychloroquine as Prophylaxis for COVID-19: A Review 84
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial 82
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 81
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial 71
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 70
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? 69
Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors 68
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors 68
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer 67
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma 66
Immunotherapy for prostate cancer: Where we are headed 66
Ipilimumab in advanced melanoma: Reports of long-lasting responses 65
Risk of Myelodysplastic Syndrome and Acute Myeloid Leukemia related to PARP inhibitor Maintenance Line in Real-world Ovarian Cancer Patients 62
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy 62
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? 60
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 58
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 56
Progress with palbociclib in breast cancer: Latest evidence and clinical considerations 55
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 54
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy 54
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer 53
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 53
Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact 53
Bevacizumab as maintenance treatment in patients with ovarian cancer: Wait for BRCA testing 51
Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer 51
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients 50
Immune system and DNA repair defects in ovarian cancer: Implications for locoregional approaches 49
Immune-checkpoint inhibitors and the importance of concomitant medications: focus on antibiotics 49
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures 49
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 46
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review 46
Metastatic bone disease in the era of bone-targeted therapy: Clinical impact 42
Psychosocial issues in long-term survivors of testicular cancer 39
Sorafenib for the treatment of breast cancer 30
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma 15
null 2
Totale 5.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.275
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022200 10 3 5 17 15 10 10 16 9 24 40 41
2022/2023283 23 37 8 37 20 24 10 12 66 7 16 23
2023/2024166 11 13 12 2 5 18 6 4 70 3 16 6
2024/20251.184 67 160 109 111 181 70 39 39 13 81 46 268
2025/20263.028 257 250 199 206 316 88 352 215 558 239 183 165
Totale 5.129